Real-time enrollment status for this recurrent glioblastoma idh wildtype clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 9:35 PM UTC
| NCT Number | NCT06455605 |
| Recruiting Status | Recruiting |
| Condition | Recurrent Glioblastoma IDH Wildtype |
| Phase | PHASE1 |
| Target Enrollment | 46 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Darell Bigner |
| Last Updated on CT.gov | October 23, 2025 (Oct 23, 2025) |
As of July 18, 2026: Clinical trial NCT06455605 is currently recruiting participants. This phase1 study for recurrent glioblastoma idh wildtype is actively seeking new participants at 1 location across the United States. The study is sponsored by Darell Bigner. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06455605 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06455605 was last updated Oct 23, 2025 (October 23, 2025). HelloStudys verifies this status automatically.